Harvard Apparatus Regenerative Technology, Inc. filed a Form D with the Securities and Exchange Commission on 2025-07-14.
Harvard Apparatus Regenerative Technology, Inc. filed a Form D notice of an exempt securities offering with the SEC on July 14, 2025. Harvard Apparatus Regenerative Technology, Inc. trades on OTC as HRGN; it was formerly Biostage, Inc. The filing reports $2M sold. Its industry group is Biotechnology. It names Junli He (Executive Officer, Director), Hong Yu (Executive Officer), William Fodor (Executive Officer) (SEC Form D, July 14, 2025).
Is this your company?
Run the free check on Harvard Apparatus Regenerative Technology, Inc. →
Sell to companies like Harvard Apparatus Regenerative Technology, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-07-14 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Harvard Apparatus Regenerative Technology, Inc.
Free to see. No signup.
More on the people and the money behind Harvard Apparatus Regenerative Technology, Inc., from the filings we hold.
Biotechnology raises by companies based in Massachusetts, filed in July 2025, largest first.
Get an email when Harvard Apparatus Regenerative Technology, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Harvard Apparatus Regenerative Technology, Inc. raises, hires or launches. No email unless you switch it on.
Watch Harvard Apparatus Regenerative Technology, Inc. →Get the full cited report on Harvard Apparatus Regenerative Technology, Inc.
What the filing shows about Harvard Apparatus Regenerative Technology, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Harvard Apparatus Regenerative Technology, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Harvard Apparatus Regenerative Technology, Inc.'s address as 84 October Hill Road, Suite 11, Holliston, MA 01746.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Harvard Apparatus Regenerative Technology, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Harvard Apparatus Regenerative Technology, Inc. See pricing
Harvard Apparatus Regenerative Technology, Inc. is a registered filer with the SEC (CIK 1563665) and has filed since 2023-04-14. 5 filings are on record, the latest on 2026-09-14.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Harvard Apparatus Regenerative Technology, Inc.'s Form D of 2025-07-14 names Junli He, Hong Yu, William Fodor and 9 more as its officers, directors or promoters.
Its new offerings report $13.03M sold across 5 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 769 filings in Biotechnology, totalled by week.
Some of the proceeds may be used for working capital and other general corporate purposes, which may include the payment of salaries and other fees to those listed in Item 3.
Junli He is named as Executive Officer and Director on the Form D that Harvard Apparatus Regenerative Technology, Inc. filed with the SEC on 14 July 2025, one of 12 people that filing names.
Hong Yu is named as Executive Officer on the Form D that Harvard Apparatus Regenerative Technology, Inc. filed with the SEC on 14 July 2025, one of 12 people that filing names.
William Fodor is named as Executive Officer on the Form D that Harvard Apparatus Regenerative Technology, Inc. filed with the SEC on 14 July 2025, one of 12 people that filing names.
Shunfu Hu is named as Executive Officer on the Form D that Harvard Apparatus Regenerative Technology, Inc. filed with the SEC on 14 July 2025, one of 12 people that filing names.
Joseph Damasio is named as Executive Officer on the Form D that Harvard Apparatus Regenerative Technology, Inc. filed with the SEC on 14 July 2025, one of 12 people that filing names.
Jing Chen is named as Director on the Form D that Harvard Apparatus Regenerative Technology, Inc. filed with the SEC on 14 July 2025, one of 12 people that filing names.
Ting Li is named as Director on the Form D that Harvard Apparatus Regenerative Technology, Inc. filed with the SEC on 14 July 2025, one of 12 people that filing names.
James Shmerling is named as Director on the Form D that Harvard Apparatus Regenerative Technology, Inc. filed with the SEC on 14 July 2025, one of 12 people that filing names.
Herman Sanchez is named as Director on the Form D that Harvard Apparatus Regenerative Technology, Inc. filed with the SEC on 14 July 2025, one of 12 people that filing names.
David Green is named as Director on the Form D that Harvard Apparatus Regenerative Technology, Inc. filed with the SEC on 14 July 2025, one of 12 people that filing names.
Ronald Packard is named as Director on the Form D that Harvard Apparatus Regenerative Technology, Inc. filed with the SEC on 14 July 2025, one of 12 people that filing names.
Mao Zhang is named as Director on the Form D that Harvard Apparatus Regenerative Technology, Inc. filed with the SEC on 14 July 2025, one of 12 people that filing names.
12 people named on the filing — 5 holding an executive role and 7 as directors only.
Named as of the 2025-07-14 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Harvard Apparatus Regenerative Technology, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Harvard Apparatus Regenerative Technology, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Harvard Apparatus Regenerative Technology, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Harvard Apparatus Regenerative Technology, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Harvard Apparatus Regenerative Technology, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Harvard Apparatus Regenerative Technology, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/harvard-apparatus-regenerative-technology-inc-form-d-25000001